EUCTR2005-003853-29-IT
Active, not recruiting
Not Applicable
A randomized, controlled, multicenter clinical trial comparing the efficacy of Peginterferon alfa-2a and ribavirin and metformin versus Peginterferon alfa-2a and ribavirin for the treatment of naïve patients with chronic hepatitis C (CHC) and insulin resistance. - ND
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO0 sitesNovember 7, 2007
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- CHRONIC ACTIVE HEPATITIS C ASSOCIATED WITH INSULIN RESISTANCE
- Sponsor
- AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
A multicenter, randomized, controlled clinical trial of Hydroxychloroquine or new Tripterygium compound in the treatment of IgA nephropathyIgA nephropathyITMCTR2100004723Peking University First Hospital
Recruiting
Phase 1
A multicenter, randomized, controlled clinical trial of efficacy and safety of xinan Guben Peiyuan formula series in the treatment of COPDChronic obstructive pulmonary diseaseITMCTR2200005834The First Affiliated Hospital of Anhui University of Chinese Medicine
Active, not recruiting
Not Applicable
Study comparing the use of a medical procedure (endoscopic band ligation) versus a drug treatment (carvedilol) to prevent bleeding of esophageal varices in patients with liver disease.Esophageal variceal bleeding in patients with cirrhosisTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2011-006208-11-ESCAIBER
Active, not recruiting
Phase 1
Study to compare the clinical and radiological efficacy of 625 mg vs 1250 mg of oral methylprednisolone in patients with multiple sclerosis in relapse.Multiple sclerosisMedDRA version: 15.0Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2012-001965-34-ESServicio de Neurología, HU. Germans Trias i Pujol
Active, not recruiting
Phase 1
Clinical trial to evaluate and compare the efficacy and safety of Hemorrane® PlusEUCTR2019-003024-20-ESFAES FARMA SA185